Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapy.
Rai
Kanti R
KR
Division of Hematology-Oncology, Long Island Jewish Medical Center, New Hyde Park, NY 11040, USA. rai@lij.edu
D015703:Antigens, CD / Q000097:blood; D000970:Antineoplastic Agents / Q000008:administration & dosage; D017209:Apoptosis / Q000187:drug effects; D001402:B-Lymphocytes / Q000378:metabolism; D015415:Biomarkers / Q000097:blood; D049109:Cell Proliferation / Q000187:drug effects; D017666:Deuterium Oxide / Q000008:administration & dosage; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000503:physiopathology* / Q000628:therapy*; D018655:Lymphocyte Count; D014411:Neoplastic Stem Cells / Q000378:metabolism; D016615:Telomere / Q000378:metabolism
D015703:Antigens, CD; D000970:Antineoplastic Agents; D015415:Biomarkers; D017666:Deuterium Oxide